IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 3 holdings | $21.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vigil Neuroscience Inc(VIGL)COM92673K108$14.2M4,214,49867.8%
Telesis BIO IncCOM192003101$3.9M9,844,13018.7%
Candel Therapeutics Inc(CADL)COM137404109$2.8M1,935,21513.5%